Nostrum Labs expands metformin drug recall
On November 4, 2020, we wrote about how Nostrum Labs joined the list of companies recalling their metformin drugs due to unsafe levels of nitrosamine (NDMA) impurities. Well they’ve now expanded on their just 2 ½ month old recall and are adding their Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the list.
Metformin HCl Extended Release Tablets, USP 750 mg
(generic equivalent to Glucophage Tablets)
Expiry Dates - 07/2022
NDMA is a human carcinogen that’s found in our water as well as our food. If you’re curious if you have the recalled drug, it can be identified by the “NM7” debossed on it. Nostrum has notified retailers, and is attempting to have the product returned. If you’re prescribed this medication, do not stop taking it until told to do so by your doctor. It could be more dangerous to cease its use than to actually take the recalled drug. Fortunately, so far no illnesses have been reported.
To read the U.S. Food and Drug Administration’s release in full, click here: https://bit.ly/39Fdgnu